Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease

29 Jul 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Folate and B Vitamins Research
Share to GDF15 and Related Biomarkers

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 39075597
DOI: 10.1186/s13024-024-00745-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s diseasePMID 39075597Read ↗

The expanding application of antisense oligonucleotides to neurodegenerative diseasesSemantic proximity Read ↗

Antisense oligonucleotide therapeutics for inherited neurodegenerative diseasesSemantic proximity Read ↗

Advancing the battle against Alzheimer's Disease: A focus on targeting tau pathology by antisense oligonucleotideSemantic proximity Read ↗

Antisense oligonucleotides: A promising advancement in neurodegenerative disease treatmentSemantic proximity Read ↗

Antisense oligonucleotides for neurodegenerationSemantic proximity Read ↗

Molecular Therapeutics in Development to Treat Alzheimer’s DiseaseSemantic proximity Read ↗

Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNASemantic proximity Read ↗

Antisense Drugs Make Sense for Neurological DiseasesSemantic proximity Read ↗

A review of the advances, insights, and prospects of gene therapy for Alzheimer’s disease: A novel target for therapeutic medicineSemantic proximity Read ↗

Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD DiseasesSemantic proximity Read ↗

Oligonucleotide-based therapy for neurodegenerative diseasesSemantic proximity Read ↗

Antisense therapies in neurological diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.